MASSACHUSETTS FINANCIAL SERVICES CO /MA/ - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 169 filers reported holding AMNEAL PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.

Quarter-by-quarter ownership
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$333,000
-12.1%
79,942
+1.0%
0.00%
Q4 2021$379,000
-12.1%
79,123
-2.0%
0.00%
Q3 2021$431,000
+2.9%
80,725
-1.3%
0.00%
Q2 2021$419,000
-23.3%
81,784
+0.9%
0.00%
Q1 2021$546,000
+31.9%
81,084
-10.6%
0.00%
Q4 2020$414,000
-71.9%
90,695
+0.8%
0.00%
-100.0%
Q2 2018$1,475,00089,9330.00%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$144,839,00011.40%
Eversept Partners, LP 4,755,480$32,004,3802.41%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$109,116,0001.27%
EAM Global Investors LLC 365,719$2,461,0000.68%
Signature Wealth Management Partners, LLC 87,666$590,0000.57%
Jackson Creek Investment Advisors LLC 221,043$1,488,0000.52%
Tranquilli Financial Advisor LLC 71,414$481,0000.39%
Hillsdale Investment Management Inc. 611,200$4,113,0000.34%
EAM Investors, LLC 259,873$1,749,0000.26%
HUSSMAN STRATEGIC ADVISORS, INC. 180,000$1,211,0000.25%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders